These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 2747747)
1. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747 [TBL] [Abstract][Full Text] [Related]
2. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. Ifudu O; Feldman J; Friedman EA N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143 [TBL] [Abstract][Full Text] [Related]
3. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801 [TBL] [Abstract][Full Text] [Related]
4. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin. Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics and clinical effect of recombinant human erythropoietin on the anemia of predialysis patients]. Yamazaki C; Itoh A; Yamamoto N; Kobayashi M; Watanabe Y; Sakamoto N Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):701-10. PubMed ID: 1479710 [TBL] [Abstract][Full Text] [Related]
6. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients]. Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of renal anemia with recombinant human erythropoietin]. Burghard R; Gordjani N; Leititis JU Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749 [TBL] [Abstract][Full Text] [Related]
8. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group. Nissenson AR Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075 [TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients. Mohini R Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516 [TBL] [Abstract][Full Text] [Related]
10. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. Schreiber S; Howaldt S; Schnoor M; Nikolaus S; Bauditz J; Gasché C; Lochs H; Raedler A N Engl J Med; 1996 Mar; 334(10):619-23. PubMed ID: 8592524 [TBL] [Abstract][Full Text] [Related]
11. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. Rao DS; Shih MS; Mohini R N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin in renal transplant recipients with renal anemia. Traindl O; Barnas U; Franz M; Falger S; Klauser R; Kovarik J; Graf H Clin Transplant; 1994 Feb; 8(1):45-8. PubMed ID: 8136567 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients. Frenken LA; Verberckmoes R; Michielsen P; Koene RA Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609 [TBL] [Abstract][Full Text] [Related]
14. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics. Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294 [TBL] [Abstract][Full Text] [Related]
16. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis]. Boratyńska M; Szewczyk Z; Szepietowski T; Czyz W; Cybulski K; Bogucki J; Szczepański J Przegl Lek; 1990; 47(11):741-5. PubMed ID: 2098840 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin. Schwartz AB; Prior JE; Mintz GS; Kim KE; Kahn SB Transplant Proc; 1991 Apr; 23(2):1827-30. PubMed ID: 2053168 [TBL] [Abstract][Full Text] [Related]
18. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients. Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762 [TBL] [Abstract][Full Text] [Related]
19. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241 [TBL] [Abstract][Full Text] [Related]
20. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients]. Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]